(1)
Ma, J. 1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, Bone Gla Protein (BGP), and Bone Turnover Markers β-Collagen Degradation Product (β-CTX), and Procollagen Type 1 N-Terminal Propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T: Serum IFCs, Bone Gla Protein (BGP), and Bone Turnover Markers β-Collagen Degradation Product (β-CTX), and Procollagen Type 1 N-Terminal Propeptide (P1NP) ). J Med Biochem 2025, 44 (3), 587-594. https://doi.org/10.5937/jomb0-51444.